MedPath

Brightgene Bio-Medical Technology Co., Ltd.

Brightgene Bio-Medical Technology Co., Ltd. logo
๐Ÿ‡จ๐Ÿ‡ณChina
Ownership
Public
Established
2001-10-26
Employees
1.1K
Market Cap
-
Website
http://www.bright-gene.com

Clinical Trials

9

Active:1
Completed:2

Trial Phases

4 Phases

Phase 1:3
Phase 2:3
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)โ€ข Click on a phase to view related trials

Phase 1
3 (33.3%)
Phase 2
3 (33.3%)
Phase 3
2 (22.2%)
Not Applicable
1 (11.1%)

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

Not Applicable
Recruiting
Conditions
Type 2 Diabetes (T2DM)
Interventions
First Posted Date
2025-07-14
Last Posted Date
2025-07-14
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
477
Registration Number
NCT07064486
Locations
๐Ÿ‡ฎ๐Ÿ‡ฉ

RS Universitas Indonesia, Depok, West Java, Indonesia

๐Ÿ‡ฎ๐Ÿ‡ฉ

RSUP Fatmawati, Jakarta, Indonesia

๐Ÿ‡ฎ๐Ÿ‡ฉ

RSUP Persahabatan, Jakarta, Indonesia

and more 1 locations

A Study of BGM0504 in Chinese Patients With Type 2 Diabetes

Phase 2
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: BGM0504 Administered SC
Drug: Semaglutide Administered SC
Drug: Placebo Administered SC
First Posted Date
2025-05-16
Last Posted Date
2025-05-16
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
67
Registration Number
NCT06974825
Locations
๐Ÿ‡จ๐Ÿ‡ณ

The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

Phase 2
Completed
Conditions
Overweight or Obesity
Interventions
Drug: Placebo
First Posted Date
2025-05-15
Last Posted Date
2025-05-15
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
120
Registration Number
NCT06973681
Locations
๐Ÿ‡จ๐Ÿ‡ณ

The Third Xiangya Hospital of Central South University, Changsha, China

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Phase 1
Recruiting
Conditions
Type 2 Diabetes Mellitus (T2DM)
Overweight or Obese
Interventions
First Posted Date
2025-04-16
Last Posted Date
2025-04-16
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
32
Registration Number
NCT06929156
Locations
๐Ÿ‡จ๐Ÿ‡ณ

The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital, Shandong Province), Jinan City, Shandong, China

A Study of BGM0504 in Overweight or Obese Participants

Phase 1
Recruiting
Conditions
Overweight or Obese
Interventions
First Posted Date
2025-04-09
Last Posted Date
2025-04-09
Lead Sponsor
BrightGene Bio-Medical Technology Co., Ltd.
Target Recruit Count
28
Registration Number
NCT06920056
Locations
๐Ÿ‡จ๐Ÿ‡ณ

The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine (Yunnan Provincial Hospital of Traditional Chinese Medicine), Kunming, Yunnan, China

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.